BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32560374)

  • 1. Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection.
    Voß F; van Beek LF; Schwudke D; Ederveen THA; van Opzeeland FJ; Thalheim D; Werner S; de Jonge MI; Hammerschmidt S
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32560374
    [No Abstract]   [Full Text] [Related]  

  • 2. Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins.
    Moffitt K; Skoberne M; Howard A; Gavrilescu LC; Gierahn T; Munzer S; Dixit B; Giannasca P; Flechtner JB; Malley R
    Infect Immun; 2014 May; 82(5):2079-86. PubMed ID: 24614661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidation of pneumococcal proteins enables activation of human antigen-presenting cells and initiation of an adaptive immune response.
    Paulikat AD; Schwudke D; Hammerschmidt S; Voß F
    Front Immunol; 2024; 15():1392316. PubMed ID: 38711516
    [No Abstract]   [Full Text] [Related]  

  • 4. Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation.
    Voß F; Kohler TP; Meyer T; Abdullah MR; van Opzeeland FJ; Saleh M; Michalik S; van Selm S; Schmidt F; de Jonge MI; Hammerschmidt S
    Front Immunol; 2018; 9():2405. PubMed ID: 30405609
    [No Abstract]   [Full Text] [Related]  

  • 5. T(H)17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins.
    Moffitt K; Howard A; Martin S; Cheung E; Herd M; Basset A; Malley R
    Clin Vaccine Immunol; 2015 Aug; 22(8):909-16. PubMed ID: 26041040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 7. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
    Goulart C; Rodriguez D; Kanno AI; Converso TR; Lu YJ; Malley R; Leite LCC
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection.
    Nagai K; Domon H; Maekawa T; Hiyoshi T; Tamura H; Yonezawa D; Habuka R; Saitoh A; Terao Y
    Vaccine; 2019 Jan; 37(1):160-168. PubMed ID: 30442480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
    PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
    Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y
    Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
    Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
    Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zangari T; Wang Y; Weiser JN
    mBio; 2017 Mar; 8(2):. PubMed ID: 28292980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
    Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
    Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.
    Talesnik E; Vial PA; Labarca J; Méndez C; Soza X
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects.
    Papadatou I; Tzovara I; Licciardi PV
    Vaccines (Basel); 2019 Jan; 7(1):. PubMed ID: 30700048
    [No Abstract]   [Full Text] [Related]  

  • 17. PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae.
    Hsu CF; Hsiao CH; Tseng SF; Chen JR; Liao YJ; Chen SJ; Lin CS; Sytwu HK; Chuang YP
    Respir Res; 2018 Sep; 19(1):187. PubMed ID: 30253765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
    Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC
    Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J; Cui YL; Jiang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):583-589. PubMed ID: 28506354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.